These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 7993908
21. Structure-function relationships of the C-terminal functional domain of hirudin and its variants. Krstenansky JL, Mao SJ. Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003 [Abstract] [Full Text] [Related]
22. Thrombin inhibition by hirudin: how hirudin inhibits thrombin. Fenton JW, Villanueva GB, Ofosu FA, Maraganore JM. Haemostasis; 1991 Feb; 21 Suppl 1():27-31. PubMed ID: 1894193 [Abstract] [Full Text] [Related]
23. Hirulog effect in rat endotoxin shock. Cicala C, Bucci MR, Maraganore JM, Cirino G. Life Sci; 1995 Feb; 57(20):PL307-13. PubMed ID: 7475925 [Abstract] [Full Text] [Related]
24. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65). Schmitz T, Rothe M, Dodt J. Eur J Biochem; 1991 Jan 01; 195(1):251-6. PubMed ID: 1991472 [Abstract] [Full Text] [Related]
27. Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor. Maraganore JM. Adv Exp Med Biol; 1993 Jan 01; 340():227-36. PubMed ID: 8154339 [No Abstract] [Full Text] [Related]
33. Kinetics of human thrombin inhibition by two novel peptide inhibitors (Hirunorm IV and Hirunorm V). Cappiello M, Vilardo PG, Lippi A, Criscuoli M, Del Corso A, Mura U. Biochem Pharmacol; 1996 Oct 25; 52(8):1141-6. PubMed ID: 8937420 [Abstract] [Full Text] [Related]
34. Characterization of the interactions of a bifunctional inhibitor with alpha-thrombin by molecular modelling and peptide synthesis. Yue SY, DiMaio J, Szewczuk Z, Purisima EO, Ni F, Konishi Y. Protein Eng; 1992 Jan 25; 5(1):77-85. PubMed ID: 1631048 [Abstract] [Full Text] [Related]
35. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding. Ayala YM, Vindigni A, Nayal M, Spolar RS, Record MT, Di Cera E. J Mol Biol; 1995 Nov 10; 253(5):787-98. PubMed ID: 7473752 [Abstract] [Full Text] [Related]
36. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. Zdanov A, Wu S, DiMaio J, Konishi Y, Li Y, Wu X, Edwards BF, Martin PD, Cygler M. Proteins; 1993 Nov 10; 17(3):252-65. PubMed ID: 8272424 [Abstract] [Full Text] [Related]
37. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis. Cheng Y, Slon-Usakiewicz JJ, Wang J, Purisima EO, Konishi Y. Biochemistry; 1996 Oct 08; 35(40):13021-9. PubMed ID: 8855937 [Abstract] [Full Text] [Related]
38. Hirulog-like peptide reduces balloon catheter injury induced neointima formation in rat carotid artery without increase in bleeding tendency. Xue M, Ren S, Welch S, Shen GX. J Vasc Res; 2001 Oct 08; 38(2):144-52. PubMed ID: 11316950 [Abstract] [Full Text] [Related]
39. Interaction of hirudin with the dysthrombins Quick I and II. Stone SR, Schmitz T, Henriksen RA, Hofsteenge J, Dodt J. Biochemistry; 1991 Jul 02; 30(26):6392-7. PubMed ID: 2054344 [Abstract] [Full Text] [Related]
40. Structural and Functional Characterization of Hirudin P6 Derived Novel Bivalent Thrombin Inhibitors - Studying the Effect of Linker Length and Glycosylation on Their Function. Shabareesh P, Kaur KJ. Chem Biol Drug Des; 2016 Jul 02; 88(1):129-41. PubMed ID: 26850929 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]